Longitudinal characterization of dysfunctional T cell-activation during human acute Ebola infection

C Agrati1,2, C Castilletti1, R Casetti2

  • 1Virology Laboratory, INMI-IRCCS "L.Spallanzani", Rome, Italy.

Cell Death & Disease
|April 1, 2016
PubMed

Insights

Ebola virus disease (EVD) causes early CD4 T-cell decline and dysfunctional T-cell activation, marked by exhaustion and impaired function. This immune subversion may contribute to EVD pathogenesis and potential late neurological complications.

Area of Science:

  • Immunology
  • Virology
  • Infectious Diseases

Background:

  • Limited data exists on immune responses during human Ebola virus disease (EVD) due to safety and logistical constraints.
  • Previous studies noted sustained T-cell activation, but functional analyses during acute EVD were lacking.

Purpose of the Study:

  • To investigate the kinetics and function of T-cell subsets during acute EVD.
  • To assess markers of T-cell activation, autophagy, apoptosis, and exhaustion until patient recovery.

Main Methods:

  • Sequential sampling and analysis of two EVD patients from symptom onset to recovery.
  • Utilized flow cytometry and ELISpot assay to evaluate T-cell subsets and functional markers.

Main Results:

  • Observed early, sustained CD4 T-cell decrease and inverted CD4/CD8 ratio, normalizing during recovery.
  • Detected massive T-cell activation with autophagic/apoptotic phenotype, increased PD-1 expression, and reduced IFN-gamma production.
  • Noted EBV reactivation alongside immunological impairment.

Conclusions:

  • Early, sustained, dysfunctional T-cell activation and CD4 T-cell decline represent a critical immune subversion mechanism in EVD.
  • Monitoring immune recovery is crucial for assessing risks of late sequelae, including EVD-associated neurological disease.
  • Further research is needed to elucidate the molecular mechanisms of EVD-driven T-cell dysfunction.

Related Concept Videos